ATE330018T1 - Expressionssysteme - Google Patents

Expressionssysteme

Info

Publication number
ATE330018T1
ATE330018T1 AT96928549T AT96928549T ATE330018T1 AT E330018 T1 ATE330018 T1 AT E330018T1 AT 96928549 T AT96928549 T AT 96928549T AT 96928549 T AT96928549 T AT 96928549T AT E330018 T1 ATE330018 T1 AT E330018T1
Authority
AT
Austria
Prior art keywords
gene
interest
pct
selectable marker
expression systems
Prior art date
Application number
AT96928549T
Other languages
English (en)
Inventor
Mary Katharine Levinge Collins
Robin Anthony Weiss
Yasuhiro Takeuchi
Francois-Lois Cosset
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of ATE330018T1 publication Critical patent/ATE330018T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96928549T 1995-08-23 1996-08-23 Expressionssysteme ATE330018T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9517263.1A GB9517263D0 (en) 1995-08-23 1995-08-23 Expression systems

Publications (1)

Publication Number Publication Date
ATE330018T1 true ATE330018T1 (de) 2006-07-15

Family

ID=10779648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928549T ATE330018T1 (de) 1995-08-23 1996-08-23 Expressionssysteme

Country Status (7)

Country Link
US (1) US6165715A (de)
EP (1) EP0846182B1 (de)
AT (1) ATE330018T1 (de)
AU (1) AU6827896A (de)
DE (1) DE69636248T2 (de)
GB (1) GB9517263D0 (de)
WO (1) WO1997008330A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070994B2 (en) * 1988-03-21 2006-07-04 Oxford Biomedica (Uk) Ltd. Packaging cells
US7235394B1 (en) * 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
EP0915975A2 (de) * 1996-07-03 1999-05-19 Chiron Corporation Methoden zur verabreichung rekombinanter genabgabevehikel zur behandlung von hämophilie
US6586661B1 (en) 1997-06-12 2003-07-01 North Carolina State University Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
ES2245042T3 (es) 1997-09-24 2005-12-16 The Regents Of The University Of California Vectores de lentivirus de no primates y sistemas de empaquetamiento.
EP1045921A2 (de) * 1998-01-16 2000-10-25 Chiron Corporation Vom immunschwächevirus der katze (fiv) abgeleiteten gentherapievektoren
WO2000071578A2 (en) * 1999-05-20 2000-11-30 Cnrs Centre National De La Recherche Scientifique New polypeptides and their use for the rescue of fusion defective virus or retrovirus glycoproteins
CA2379207A1 (en) * 1999-07-09 2001-01-18 Uab Research Foundation Retroviral recombination assays and uses thereof
DE60024659T2 (de) 1999-10-13 2006-08-17 Immunex Corp., Thousand Oaks Vektoren und verfahren für rekombinante proteinexpression
US6849454B2 (en) 2000-03-07 2005-02-01 St. Jude Children's Research Hospital Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles
EP1313868B1 (de) * 2000-08-30 2006-07-19 North Carolina State University Transgene pflanzen, die molekulare decoys enthalten, die den proteininhalt ändern
EP1368467B1 (de) 2000-11-07 2007-04-25 North Carolina State University Putrescin-n-methyltransferasepromotor
NZ530238A (en) * 2001-06-08 2004-08-27 Vector Tobacco Ltd Modifying nicotine and nitrosamine levels in tobacco
AU2002331365B2 (en) * 2001-08-02 2007-11-15 Altana Pharma Ag Novel recombinant gene expression method by stop codon suppression
TW200613554A (en) * 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
ATE373081T1 (de) * 2004-09-30 2007-09-15 Reneuron Ltd Zelllinie
WO2010147464A1 (en) * 2009-06-15 2010-12-23 Cellagenics B.V. Use of a cysteine synthesizing enzyme as selectable marker
DK2611915T3 (da) 2010-09-01 2015-06-22 Cellagenics B V Nukleinsyrefragmenter fra en ribosomal proteinpromoter til forstærkning af genekspression
GB201202516D0 (en) 2012-02-13 2012-03-28 Ucl Business Plc Materials and methods relating to packaging cell lines
WO2021216621A2 (en) 2020-04-20 2021-10-28 Vestaron Corporation Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
AU2021265277A1 (en) 2020-05-01 2022-12-08 Vestaron Corporation Insecticidal combinations
WO2022212863A1 (en) 2021-04-01 2022-10-06 Vestaron Corporation Liposome formulations for pesticide delivery and methods for producing and using the same
IL307293A (en) 2021-04-01 2023-11-01 Vestaron Corp AV3 mutant polypeptides for pest control
WO2022235929A1 (en) 2021-05-05 2022-11-10 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
AR129351A1 (es) 2022-05-18 2024-08-14 Vestaron Corp Variantes de péptidos pesticidas actx
WO2023245100A1 (en) 2022-06-17 2023-12-21 Vestaron Corporation Antimicrobial ncr13 variant peptides
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232438T2 (de) * 1991-08-07 2002-10-10 W. French Anderson Interne ribosom eintrittsstellen enthaltene retrovirale vektoren
EP0644946A4 (de) * 1992-06-10 1997-03-12 Us Health Gegen die inaktivierung durch menschliches serum resistente vektorpartikel.
EP0706319A4 (de) * 1993-01-20 1998-04-22 Biotransplant Inc Retrovirale vektoren mit der fähigkeit zur expression multimerer proteine von mehreren translationsinitiations-orten
DE69420033T2 (de) * 1993-04-06 1999-12-23 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Bethesda Gibbon leukemia virus retrovirale vektoren

Also Published As

Publication number Publication date
AU6827896A (en) 1997-03-19
EP0846182B1 (de) 2006-06-14
US6165715A (en) 2000-12-26
EP0846182A1 (de) 1998-06-10
DE69636248D1 (de) 2006-07-27
GB9517263D0 (en) 1995-10-25
DE69636248T2 (de) 2007-04-19
WO1997008330A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
DE69636248D1 (de) Expressionssysteme
FR2708622B1 (fr) Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
GB9715660D0 (en) Proteins
FI965031A (fi) Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni
FI942228A0 (fi) Bacillus licheniformiksen x-amylaasipromoottorin variantista johdettu Bacillus-promoottori
DK0758383T3 (da) Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof
DK0677109T3 (da) Ekspressionssystem til fremstilling af apolipoprotein AI-M
AU7489687A (en) Translation of mrna
DE69730218D1 (de) Fusogene liposomen
DK0655890T3 (da) Rekombinante celler, DNA-konstruktioner, vektorer og fremgangsmåder til ekspression af phytatnedbrydende enzymer i önskede forhold
DE69314339D1 (de) Auf proteinbasis beruhendes liefersystem
DE69214146D1 (de) Deletionsmutanten von bovinem herpuvirus-1, auf diese basierte impfstoffe,diagnosesätze für den nachweis von bovinem herpesvirus-1
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
ATE408015T1 (de) Transfer system basierend auf einem fusionsprotein und seine anwendungen.
DE69731463D1 (de) Rekombinante ribonuklease proteine
DK1045901T3 (da) Ribozymale nucleinsyrer, der spalter CCR5 eller CXCR4
AU7854394A (en) Virus resistant or tolerant cells
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
NO20006026L (no) Fremgangsmåter og blandinger for modulering av angiogenese ved bruk av tyrosin kinase SRC
DK0652964T3 (da) Promotor af K. lactis transaldolasegenet og anvendelse heraf
CA2139430A1 (fr) Polypeptides ayant une activite de recepteur serotoninergique (5ht5a), acides nucleiques codant pour ces polypeptides et utilisations
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
Piskurich Molecular cloning and regulation of the polymeric immunoglobulin receptor
Taylor Regulation of the metastatic phenotype by growth factors and oncogenes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0846182

Country of ref document: EP